Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Brea...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 /PRNewswire-AsiaNet/ -- Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) p...
Authors: LATEST ASIANET NEWS RELEASES